These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 9920352

  • 1. Effects of sex steroids on proliferation in normal mammary tissue.
    Söderqvist G.
    Ann Med; 1998 Dec; 30(6):511-24. PubMed ID: 9920352
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
    Mueck AO, Seeger H, Wallwiener D.
    Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
    [Abstract] [Full Text] [Related]

  • 3. Sex steroids and breast cancer prevention.
    Spicer DV, Pike MC.
    J Natl Cancer Inst Monogr; 1994 Sep; (16):139-47. PubMed ID: 7999456
    [Abstract] [Full Text] [Related]

  • 4. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA, Oza BP, Colomer R, Lupu R.
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [Abstract] [Full Text] [Related]

  • 5. Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells.
    Seeger H, Rakov V, Mueck AO.
    Horm Metab Res; 2005 Aug; 37(8):468-73. PubMed ID: 16138258
    [Abstract] [Full Text] [Related]

  • 6. The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells.
    Krämer EA, Seeger H, Krämer B, Wallwiener D, Mueck AO.
    Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):77-83. PubMed ID: 16460873
    [Abstract] [Full Text] [Related]

  • 7. Potential benefits of estrogens and progestogens on breast cancer.
    Schneider HP, Jackisch C.
    Int J Fertil Womens Med; 1998 Nov; 43(6):278-85. PubMed ID: 9920536
    [Abstract] [Full Text] [Related]

  • 8. Breast cancer risk during hormone therapy: experimental versus clinical data.
    Ruan X, Seeger H, Mueck AO.
    Minerva Endocrinol; 2012 Mar; 37(1):59-74. PubMed ID: 22382615
    [Abstract] [Full Text] [Related]

  • 9. Hormonal and environmental factors affecting cell proliferation and neoplasia in the mammary gland.
    Snedeker SM, Diaugustine RP.
    Prog Clin Biol Res; 1996 Mar; 394():211-53. PubMed ID: 8778798
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
    Wood CE, Register TC, Lees CJ, Chen H, Kimrey S, Cline JM.
    Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
    [Abstract] [Full Text] [Related]

  • 12. [Cancer risk under hormone therapy].
    Lauritzen C.
    Ther Umsch; 1994 Nov; 51(11):755-66. PubMed ID: 7839334
    [Abstract] [Full Text] [Related]

  • 13. Comparative effects of oral conjugated equine estrogens and micronized 17beta-estradiol on breast proliferation: a retrospective analysis.
    Wood CE, Clarkson TB, Chen H, Veenstra TD, Xu X, Scott L, Cline JM.
    Menopause; 2008 Nov; 15(5):890-8. PubMed ID: 18520696
    [Abstract] [Full Text] [Related]

  • 14. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
    Seeger H, Wallwiener D, Mueck AO.
    Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101
    [Abstract] [Full Text] [Related]

  • 15. [The present state of research on the relationship of oral contraceptives to breast cancer].
    Pike MC.
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oestrogens, progestins and breast proliferation.
    Thijssen JH.
    Zentralbl Gynakol; 1997 Jan; 119 Suppl 2():43-7. PubMed ID: 9361394
    [Abstract] [Full Text] [Related]

  • 18. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [Abstract] [Full Text] [Related]

  • 19. [Hormonal contraception and substitution therapy: the importance of progestogen for cardiovascular diseases].
    Kuhl H.
    Geburtshilfe Frauenheilkd; 1992 Nov; 52(11):653-62. PubMed ID: 1452000
    [Abstract] [Full Text] [Related]

  • 20. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T, Kolodziejczyk J, Krzysiek J, Basta A, Sztefko K, Kurek S, Stachura J, Gregoraszczuk EL.
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.